Navigation Links
Researchers isolate protein domain linked to tumor progression
Date:2/17/2009

Troy, N.Y. When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix metalloproteinases (MMPs). Now, researchers at Rensselaer Polytechnic Institute have shown that creating drugs that inactivate a different part of the MMP enzyme could have the capacity to target the tumor without the damaging side effects. Their findings, which hold promise for improved cancer therapies, were published Feb. 5 in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS).

"The failure of the clinical trials suggest that the proteinases were not only involved in the pathology of the disease, but also in maintaining the normal health of the patient," said Andrea Page-McCaw, assistant professor of biology at Rensselaer and the corresponding author of the study. Page-McCaw and her colleagues, including senior research specialist Bernadette M. Glasheen and undergraduate biology student Aasish Kabra, set out to determine the functions of different parts of an MMP enzyme. These parts, known as domains, usually correlate to a specific protein function. Inactivating one domain within a protein can often have significant and unknown consequences.

To determine MMP domain function, the researchers used a simple model organism, the common fruit fly. Unlike mouse and other mammal models that have 24 or more different and semi-redundant MMPs, the fly model has only two. This substantially simplifies the problem of understanding function of each domain, as there aren't so many other closely related proteins that can fill in if a domain on one is broken.

The researchers found that a domain known as the hemopexin domain was important for tissue invasion events. During tissue invasion, cells from one tissue invade into and usually move through another tissue, sometimes ending up in a completely differ
'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. CSHL researchers identify gene that helps plant cells keep communication channels open
2. Researchers identify gene linked to aggressive progression of liver cancer
3. Case Western Reserve researchers looking at light-induced toxins in air and water
4. McMaster researchers discover new mode of how diseases evolve
5. Researchers shed new light on connection between brain and loneliness
6. Texas researchers provide emissions data for livestock industry
7. Biodiversity itself begets a species cascade, researchers say
8. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
9. While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy
10. NSF-funded workshops help young researchers teach science
11. Researchers observe evolution chain reaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
(Date:1/22/2015)... WINSTON-SALEM, N.C. , Jan. 16, 2015  A man-made ... working memory and other mental capabilities in adults with ... a pilot study led by researchers at Wake Forest ... 60 adults diagnosed with amnesic mild cognitive impairment (MCI) ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... for cystic fibrosis, HIV-fighting ,Trojan horses, new pharmaceuticals from ... to discover medications of the future. ,On 24 August, ... an international conference in Gothenburg, Sweden. In ... to investigate, and eventually control, the behavior of cells. ...
... researcher is challenging health standards that consider nitrates and ... research suggests that although there are negative health effects ... nitrates in groundwater, nitrates and nitrites -- as they ... Nitrate and nitrite are naturally occurring ions associated ...
... visceral fat, more commonly called belly fat, is known to ... causes visceral fat to accumulate? The culprit is likely ... hormone balance that occurs during the menopause transition, according to ... factors we analyzed that could possibly account for the increase ...
Cached Biology News:10th Functional Genomics: Chemical Biology 2009 2Research supports calls to study health benefits of nitrate, nitrite 2Increase in visceral fat during menopause linked with testosterone 2
(Date:3/3/2015)... 2015  Regenicin, Inc. (OTC Bulletin Board: ... of and commercialization of regenerative cell therapies to restore ... that it has received the final payment to conclude ... (OTC Bulletin Board: AMBS ). ... final payments due to Regenicin in the amount of ...
(Date:3/3/2015)... The winners of awards for supply ... the Global Supply Chain Resiliency Council (GSCRC) ... Wednesday, February 25th, 2015, at the Hyatt Regency in ... bring together supply chain risk management and resiliency practitioners ... discipline through opportunities to collaborate, develop and share best ...
(Date:3/3/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or ... Expert Opinion on Biological Therapy , Dr. Michael ... , at the Henry Ford Hospital in ... (TB4) has the capacity to promote CNS and peripheral ... leading to neurological recovery in each case.  They pointed ...
(Date:3/3/2015)... , March 3, 2015  Rosa & Co. ... drug-disease modeling and simulation research, today announced it has ... American Society for Clinical Pharmacology and Therapeutics meeting in ... 2015.   Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... will present a poster describing a quantitative systems pharmacology ...
Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
... ... and a Complete Set of Intuitive Gene-Building Tools , ... (PRWEB) June 17, 2010 -- DNA2.0 , the leading gene ... designing DNA sequences: Gene Designer 2.0 . Building on the success of the original ...
... , ... extracellular matrix (hECM) produced under proprietary conditions of hypoxia and suspension have demonstrated its ability ... in vitro and in vivo. , ... SAN DIEGO, CA (PRWEB) June 17, 2010 - Histogen, Inc., a regenerative medicine ...
... DUBLIN , June 17, 2010 ... 24 hour blood,pressure is more accurate and consistent than a leading group ... , ... , the study,analysed the interpretation of numerous blood pressure readings taken over ...
Cached Biology Technology:DNA2.0 Introduces Powerful, Free Gene Design Software 2DNA2.0 Introduces Powerful, Free Gene Design Software 3DNA2.0 Introduces Powerful, Free Gene Design Software 4Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation 2Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation 3Independent Study Reveals dabl System Leads the way in Accurate Cardiovascular Diagnosis 2Independent Study Reveals dabl System Leads the way in Accurate Cardiovascular Diagnosis 3
nuclear RNA export factor 1, mRNA...
The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or ...
... analysis of gene expression) technology ... Expression profiles generated by SAGE ... low-abundance transcripts making it possible ... I-SAGE Kit is designed to ...
... ultimate in utility and flexibility press-to-seal silicone ... needs of the researcher. They are available ... as sheet material that can be easily ... are autoclavable and non-cytotoxic and can be ...
Biology Products: